Gene · 406987
Papers4,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome profiling and network enrichment analyses identify subtype-specific therapeutic gene targets for breast cancer and their microRNA regulatory networks. | Cell Death Dis | 2023 | 37438342 | PubTator, text mining | PubMed |
| LncRNA BBOX1-AS1 Contributes to the Development of Nasopharyngeal Carcinoma via miR-204-5p/MUC4 Axis. | Ann Clin Lab Sci | 2023 | 37437933 | PubTator, text mining | PubMed |
| Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues. | Aging (Albany NY) | 2023 | 37437245 | PubTator, text mining | PubMed |
| Apoptotic effects of human amniotic fluid mesenchymal stem cells conditioned medium on human MCF-7 breast cancer cell line. | Bioimpacts | 2023 | 37431479 | PubTator, text mining | PubMed |
| Cell Cycle-Related lncRNAs as Innovative Targets to Advance Cancer Management. | Cancer Manag Res | 2023 | 37426392 | PubTator, text mining | PubMed |
| Retracted: Serum miR-204 and miR-451 Expression and Diagnostic Value in Patients with Pulmonary Artery Hypertension Triggered by Congenital Heart Disease. | Comput Math Methods Med | 2023 | 37416281 | PubTator, text mining | PubMed |
| Aberrant expression of miR-33a-3p/IGF2 in postmenopausal osteoporosis patients and its role and mechanism in osteoporosis. | J Orthop Surg Res | 2023 | 37415192 | PubTator, text mining | PubMed |
| Variations in EXD3 caused congenital cataracts in three Chinese families. | Genes Dis | 2023 | 37396523 | PubTator, text mining | PubMed |
| High-fat diet-induced gut microbiota alteration promotes lipogenesis by butyric acid/miR-204/ACSS2 axis in chickens. | Poult Sci | 2023 | 37390560 | PubTator, text mining | PubMed |
| Retracted: Study on Serum miR-204 Expression Levels in Patients with Severe Pneumonia and Patients with Primary Bronchial Lung Cancer and Its Diagnostic Value. | Evid Based Complement Alternat Med | 2023 | 37387834 | PubTator, text mining | PubMed |
| Non-Coding RNAs and Adipogenesis. | Int J Mol Sci | 2023 | 37373126 | PubTator, text mining | PubMed |
| Gold Nanoparticles Inhibit PMA-Induced MMP-9 Expression via microRNA-204-5p Upregulation and Deactivation of NF-κBp65 in Breast Cancer Cells. | Biology (Basel) | 2023 | 37372062 | PubTator, text mining | PubMed |
| A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma. | Cells | 2023 | 37371047 | PubTator, text mining | PubMed |
| MicroRNAs' Role in Diagnosis and Treatment of Subarachnoid Hemorrhage. | Diseases | 2023 | 37366865 | PubTator, text mining | PubMed |
| Ocular-Surface Regeneration Therapies for Eye Disorders: The State of the Art. | BioTech (Basel) | 2023 | 37366796 | PubTator, text mining | PubMed |
| Novel insights into mutual regulation between N6-methyladenosine modification and LncRNAs in tumors. | Cancer Cell Int | 2023 | 37365581 | PubTator, text mining | PubMed |
| Integrated bioinformatics and wet-lab analysis revealed cell adhesion prominent genes CDC42, TAGLN and GSN as prognostic biomarkers in colonic-polyp lesions. | Sci Rep | 2023 | 37365287 | PubTator, text mining | PubMed |
| NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia. | Oncol Rep | 2023 | 37350410 | PubTator, text mining | PubMed |
| The role of microRNAs in nicotine signaling. | EXCLI J | 2023 | 37346805 | PubTator, text mining | PubMed |
| Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment. | Cancers (Basel) | 2023 | 37345024 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406987/papers?page=19